Home Tags Phase 2 TRIO-US B-12 TALENT trial

Tag: phase 2 TRIO-US B-12 TALENT trial

Trastuzumab Deruxtecan Demonstrates Clinical Activity in Neoadjuvant Setting in Patients with...

Patients diagnosed with hormone receptor-positive (HR+)/HER2-negative breast cancer frequently experience disease response to neoadjuvant therapy. However, following standard chemotherapy or endocrine therapy, even in combination with CDK4/6...

X